Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Antibiotic | Research

Effect of the “Normalized Epidemic Prevention and Control Requirements” on hospital-acquired and community-acquired infections in China

Authors: Caiyun Chen, Ping Zhu, Yongxiang Zhang, Bo Liu

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

No studies have yet reported the effect of prevention and control measures, which were implemented to combat COVID-19, on the prevention and control of common HAIs. We aimed to examine the effect of the “Normalized Epidemic Prevention and Control Requirements” (implemented in May 2020) by comparison of hospital-acquired infections (HAIs) and community-acquired infections (CAIs) in China during 2018, 2019, and 2020.

Methods

Data of inpatients before and after implementation of new requirements were retrospectively analyzed, including infection rate, use of alcohol-based hand cleaner, anatomical sites of infections, pathogen species, infection by multi-drug resistant species, and use of different antibiotics.

Results

The HAI rate was significantly higher in 2020 than in 2018 and 2019 (P < 0.05), and the CAI rate was significantly higher in 2019 and 2020 than in 2018 (P < 0.001). Lower respiratory tract infections were the most common HAI during all years, with no significant changes over time. Lower respiratory tract infections were also the most common CAI, but were significantly more common in 2018 and 2019 than 2020 (P < 0.001). There were no changes in upper respiratory tract infections among HAIs or CAIs. Most HAIs and CAIs were from Gram-negative bacteria, and the percentages of fungal infections were greater in 2019 and 2020 than 2018. MRSA infections were more common in 2020 than in 2018 and 2019 (P < 0.05). The utilization rate and usage days of antibiotics decreased over time (P < 0.001) and the culture rate of microbial specimens before antibiotic usage increased over time (P < 0.001).

Conclusions

The new prevention and control requirements provided important benefits during the COVID-19 pandemic. However, their effects on HAIs were not obvious.
Literature
1.
go back to reference Contini C, Di Nuzzo M, Barp N, et al. The novel zoonotic COVID-19 pandemic: an expected global health concern. J Infect Dev Countries. 2020;14(3):254–64.CrossRef Contini C, Di Nuzzo M, Barp N, et al. The novel zoonotic COVID-19 pandemic: an expected global health concern. J Infect Dev Countries. 2020;14(3):254–64.CrossRef
3.
go back to reference Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: a brief overview. Anesth Analg. 2020;131(1):93–6.CrossRef Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: a brief overview. Anesth Analg. 2020;131(1):93–6.CrossRef
4.
go back to reference Wang Y, Grunewald M, Perlman S. Coronaviruses: an updated overview of their replication and pathogenesis. Methods Mol Biol. 2020;2203:1–29.CrossRef Wang Y, Grunewald M, Perlman S. Coronaviruses: an updated overview of their replication and pathogenesis. Methods Mol Biol. 2020;2203:1–29.CrossRef
5.
go back to reference Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res. 2020;7(1):11.PubMedPubMedCentral Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res. 2020;7(1):11.PubMedPubMedCentral
9.
go back to reference Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.CrossRef Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.CrossRef
10.
go back to reference Hong S, Yusan W, Ziyu S. National clinical laboratory operating procedures. 4th ed. Beijing: People’s Health Publishing House; 2015. p. 629–45. Hong S, Yusan W, Ziyu S. National clinical laboratory operating procedures. 4th ed. Beijing: People’s Health Publishing House; 2015. p. 629–45.
11.
go back to reference Clinical Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing (2017) CLSI approved standards CLSI M100-S23. Wayne, PA: CLSI; 2017. Clinical Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing (2017) CLSI approved standards CLSI M100-S23. Wayne, PA: CLSI; 2017.
12.
go back to reference Huang X, Deng Z, Ni Y, et al. Chinese experts, consensus on prevention and control of multidrug resistance organism healthcare-associated infection. Chin J Infect Control. 2015;14(1): 1–9. 2008.03.002. Huang X, Deng Z, Ni Y, et al. Chinese experts, consensus on prevention and control of multidrug resistance organism healthcare-associated infection. Chin J Infect Control. 2015;14(1): 1–9. 2008.03.002.
13.
go back to reference Zhao Y, Cheng S, Yu X, et al. Chinese public’s attention to the COVID-19 epidemic on social media: observational descriptive study. J Med Internet Res. 2020;22(5):e18825.CrossRef Zhao Y, Cheng S, Yu X, et al. Chinese public’s attention to the COVID-19 epidemic on social media: observational descriptive study. J Med Internet Res. 2020;22(5):e18825.CrossRef
14.
go back to reference Ling-fang LV, Zhang HY, Zhou CL. Analysis of surveillance data of nosocomial infections in a level A tertiary hospital from 2014 to 2018. Chin J Disinfect. 2020;37(5):355–8. Ling-fang LV, Zhang HY, Zhou CL. Analysis of surveillance data of nosocomial infections in a level A tertiary hospital from 2014 to 2018. Chin J Disinfect. 2020;37(5):355–8.
15.
go back to reference Yao H, Huo R, Liu Y, et al. Incidence of healthcare-associated infections in a tertiary hospital in Beijing, China: results from a real-time surveillance system. Antimicrob Resist Infect Control. 2019;8:145.CrossRef Yao H, Huo R, Liu Y, et al. Incidence of healthcare-associated infections in a tertiary hospital in Beijing, China: results from a real-time surveillance system. Antimicrob Resist Infect Control. 2019;8:145.CrossRef
16.
go back to reference Ren N, Wen X, Wu A. Nationwide cross-sectional survey on healthcare-associated infection in 2014. Chin J Infect Control. 2016;15(2):83–7. Ren N, Wen X, Wu A. Nationwide cross-sectional survey on healthcare-associated infection in 2014. Chin J Infect Control. 2016;15(2):83–7.
17.
go back to reference Cawcutt KA, Marcelin JR, Silver JK. Using social media to disseminate research in infection prevention, hospital epidemiology, and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2019;40(11):1262–8.CrossRef Cawcutt KA, Marcelin JR, Silver JK. Using social media to disseminate research in infection prevention, hospital epidemiology, and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2019;40(11):1262–8.CrossRef
18.
go back to reference Siracusa M, Scuri S, Grappasonni I, et al. Healthcare acquired infections: malpractice and litigation issues. Ann Ig. 2019;31(5):496–506.PubMed Siracusa M, Scuri S, Grappasonni I, et al. Healthcare acquired infections: malpractice and litigation issues. Ann Ig. 2019;31(5):496–506.PubMed
19.
go back to reference Fredj SB, Cheikh AB, Bhiri S, et al. Multimodal intervention program to improve hand hygiene compliance: effectiveness and challenges. J Egypt Public Health Assoc. 2020;95(1):11.CrossRef Fredj SB, Cheikh AB, Bhiri S, et al. Multimodal intervention program to improve hand hygiene compliance: effectiveness and challenges. J Egypt Public Health Assoc. 2020;95(1):11.CrossRef
20.
go back to reference Gutierrez J, Alloubani A, Alzaatreh M, et al. Impact of an interventional program on improving compliance of hand hygiene and reducing hospital-acquired infection in the critical care unit. J Glob Infect Dis. 2021;13(2):80–4.CrossRef Gutierrez J, Alloubani A, Alzaatreh M, et al. Impact of an interventional program on improving compliance of hand hygiene and reducing hospital-acquired infection in the critical care unit. J Glob Infect Dis. 2021;13(2):80–4.CrossRef
21.
go back to reference Wetzker W, Bunte-Schönberger K, Walter J, et al. Use of ventilator utilization ratio for stratifying alcohol-based hand-rub consumption data to improve surveillance on intensive care units. J Hosp Infect. 2017;95(2):185–8.CrossRef Wetzker W, Bunte-Schönberger K, Walter J, et al. Use of ventilator utilization ratio for stratifying alcohol-based hand-rub consumption data to improve surveillance on intensive care units. J Hosp Infect. 2017;95(2):185–8.CrossRef
22.
go back to reference Kramer TS, Walter J, Schröder C, et al. Increase in consumption of alcohol-based hand rub in German acute care hospitals over a 12 year period. BMC Infect Dis. 2021;21(1):766.CrossRef Kramer TS, Walter J, Schröder C, et al. Increase in consumption of alcohol-based hand rub in German acute care hospitals over a 12 year period. BMC Infect Dis. 2021;21(1):766.CrossRef
23.
go back to reference Dalton KR, Rock C, Carroll KC, et al. One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections. Antimicrob Resist Infect Control. 2020;9(1):78.CrossRef Dalton KR, Rock C, Carroll KC, et al. One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections. Antimicrob Resist Infect Control. 2020;9(1):78.CrossRef
24.
go back to reference Sheng B, Ye Y, Li J. Nosocomial infection: an analysis and investigation of 70160 inpatients cases. Anhui Med Pharm J. 2017;21(1):77–81. Sheng B, Ye Y, Li J. Nosocomial infection: an analysis and investigation of 70160 inpatients cases. Anhui Med Pharm J. 2017;21(1):77–81.
25.
go back to reference Pathakumari B, Liang G, Liu W. Immune defence to invasive fungal infections: a comprehensive review. Biomed Pharmacother. 2020;130:110550.CrossRef Pathakumari B, Liang G, Liu W. Immune defence to invasive fungal infections: a comprehensive review. Biomed Pharmacother. 2020;130:110550.CrossRef
26.
go back to reference De Waele JJ, Boelens J, Leroux-Roels I, et al. Multidrug-resistant bacteria in ICU: fact or myth. Curr Opin Anaesthesiol. 2020;33(2):156–61.CrossRef De Waele JJ, Boelens J, Leroux-Roels I, et al. Multidrug-resistant bacteria in ICU: fact or myth. Curr Opin Anaesthesiol. 2020;33(2):156–61.CrossRef
27.
go back to reference Karanika S, Paudel S, Grigoras C, et al. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016;60(8):4840–52.CrossRef Karanika S, Paudel S, Grigoras C, et al. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016;60(8):4840–52.CrossRef
Metadata
Title
Effect of the “Normalized Epidemic Prevention and Control Requirements” on hospital-acquired and community-acquired infections in China
Authors
Caiyun Chen
Ping Zhu
Yongxiang Zhang
Bo Liu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06886-y

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.